I am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter @theroberthart or email me at [email protected]
Shionogi announced positive results for its antiviral pill to treat Covid.In a televised parliamentary committee meeting, Kishida said the government would like to review Shionogi’s drug “promptly,” assuming its safety and efficacy are confirmed by clinical trials, Reuters reported.
The antiviral reduced virus levels in Covid-positive patients by as much as 80% after four days compared to a placebo group, the Japanese drugmakerVirus levels in patients taking a smaller dose of the drug fell by 63% compared to the placebo group. it is ready to begin a global Phase 3 trial—a large-scale, late-stage clinical trial—and data from the earlier trial will be ready within a few weeks.
Chief Executive Isao Teshirogi told reporters the company could file for regulatory approval in Japan as soon as next week, according to Reuters. 1 million. That’s how many people Shionogi could have enough doses manufactured to treat by the end of March, the company said. It expects it can produce enough for 10 million people a year after April. The development of effective antiviral pills was a milestone in the fight against the coronavirus.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ice hockey-China upset rivals Japan in tense shootout, U.S. best SwissChina ended Japan's unbeaten streak in the Olympic women's ice hockey tournament on Sunday, upsetting their rivals 2-1 in a tense shootout win, while the United States locked up a routine win over Switzerland.
Read more »
Covid-19 Pill Competing With Pfizer’s Looks for Quick Approval in JapanJapanese drugmaker Shionogi says its pill offers advantages over Paxlovid because it is taken once a day without any additional medication.
Read more »
Japan stocks poised for lower start; mainland China markets set to reopen after Lunar New Year holidaysMainland China markets are set to return to trade on Monday after being closed last week for the Lunar New Year holidays.
Read more »
Covid-19 Pill Competing With Pfizer’s Looks for Quick Approval in JapanJapanese drugmaker Shionogi says its pill offers advantages over Paxlovid because it is taken once a day without any additional medication.
Read more »
COVID-19 and omicron fading fast in Pa., latest data showsThe rate of deaths, however, is taking longer to fall, with the state fast closing in on 42,000.
Read more »